Home > Widening the availability of naloxone.

United Kingdom. Department of Health, Medicines & Healthcare products Regulatory Agency, Public Health England. (2015) Widening the availability of naloxone. London: Government Publications. 6 p.

[img]
Preview
PDF (Widening the availability of naloxone)
54kB

Naloxone is the emergency antidote for overdoses caused by heroin and other opiates/opioids (such as methadone and morphine). The main life-threatening effect of heroin and other opiates is to slow down and stop breathing. Naloxone blocks this effect and reverses the breathing difficulties.

Contents:
1. What the new regulations mean
2. Who can supply naloxone
3. Products that drug services can supply
4. Responsibility for deciding who can actually supply naloxone locally
5. People who can be supplied naloxone
6. Patient Group Directions and Patient Specific Directions
7. Naloxone’s status as a prescription only medicine
8. Using naloxone to save a person’s life without their permission
9. Clinical governance in drug treatment services
10. Guidance for hostels/homeless shelters/housing associations, etc
11. The cost-effectiveness of widening availability
12. Risks associated with widening availability
13. Further advice

[Note: this guidance applies to the United Kingdom]


Item Type:Evidence resource
Publication Type:Guideline
Drug Type:Opioid
Intervention Type:AOD disorder harm reduction
Date:2015
Pages:6 p.
Publisher:Government Publications
Corporate Creators:United Kingdom. Department of Health, Medicines & Healthcare products Regulatory Agency, Public Health England
Place of Publication:London
EndNote:View
Subjects:B Substances > Opioids (opiates)
B Substances > Opioids (opiates) > Opioid product > Naloxone
G Health and disease > Substance use disorder > Drug use > Drug intoxication > Poisoning (overdose)
P Demography, epidemiology, and history > Population dynamics > Substance related mortality / death
VA Geographic area > Europe > United Kingdom

Repository Staff Only: item control page